Sanya Sukduang has over twenty years of experience litigating life science patent disputes, including cases involving Hatch-Waxman Abbreviated New Drug Application challenges for brand drug manufacturers, biological products and medical devices. Drawing from his extensive litigation experience, Sanya also advises clients on an array of pre-litigation and acquisition due diligence investigations and strategic patent portfolio planning.

Download full bio 


  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

[Sanya] has great vision and a disarming personality – as opposing counsel, you might not notice what ‘litigation thing’ he is doing to you. – Intellectual Asset Management Patent 1000

  • American University, Washington College of Law
    JD, cum laude, 1999

  • Boston College
    BS, Biology

Admissions & Credentials

District of Columbia


United States Patent & Trademark Office


  • American Intellectual Property Law Association

  • National Asian Pacific American Bar Association

  • Thai American Bar Association

Rankings & Accolades

    LMG Life Sciences Shortlist, General Patent Litigator of the Year, DC Metro (2021)

    Legal 500: Healthcare: Life Sciences; Patents: Litigation (2021)

    IAM Patent 1000 List for Patent Litigation (2018 – 2020)

    LMG Life Sciences Star (2012 – 2021)

    Managing Intellectual Property Shortlist – Outstanding Litigator, District of Columbia (2017)

    LMG Life Sciences Shortlist, General Patent Litigator of the Year, DC (2016 – 2017)

    NAPABA Best Lawyers Under 40 (2013)

    Eli Lilly and Company Quality Advocate Award (2011)